Open access
Jul 2026
FZD5 drives macrophage-mediated immunomodulation and predicts prognosis in glioma: evidence from single-cell sequencing
FZD5 is a TAM-enriched marker in glioma tissues and a potential regulator of macrophage-associated immunosuppressive programs, supporting its utility as a prognostic biomarker and a candidate target for microenvironment-oriented interventions in glioma.
Jiong-Yuan Pei, Chen Huang, Chan-Tian Jiang et al.
· BMC Cancer · 0 citations